Bioinvent: The Covid-19 impact seems limited so far

Research Note

2020-03-27

09:21

Yesterday’s business update indicates only minor delays in ongoing studies, with no changes in the time table, why we reiterate our valuation of Bioinvent.

KP

Klas Palin

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.